We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 938.40 | 940.00 | 941.60 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNMC
RNS Number : 9983N
NMC Health Plc
27 September 2019
NMC Health plc
Exercise of options
London 27(th) September 2019: NMC Health plc (LSE:NMC) ('NMC'), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, announces that on 26(th) September 2019, Prasanth Manghat (Chief Executive Officer and Executive Director), exercised various nil-cost share options over 133,728 shares, granted to him in 2016, 2017 & 2018 under the Company's Long Term Investment Plans ("LTIP") and Deferred Share Bonus Plans ("DSBP").
Following this transaction, Mr Manghat has an interest over a total of 388,000 shares, representing approximately 0.18% of the issued share capital of the Company.
The Notification of Dealing Form for Mr Manghat can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Prasanth Manghat --------------------- ----------------------------------------------- 2 Reason for the notification ---------------------------------------------------------------------- a) Position/status Chief Executive Officer and Executive Director --------------------- ----------------------------------------------- b) Initial notification Initial notification /Amendment --------------------- ----------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------------- a) Name NMC Health plc --------------------- ----------------------------------------------- b) LEI 2138008YQEVWBE1V2M52 --------------------- ----------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------------- a) Description Options over ordinary Shares of the financial instrument, ISIN: GB00B7FC0762 type of instrument Identification code --------------------- ----------------------------------------------- b) Nature of Exercise of Nil-cost options the transaction --------------------- ----------------------------------------------- c) Price(s) and Share Total Shares volume(s) plan for allotment LTIP 86,435 ------- --------------- DSBP 15,191 ------- --------------- DSBP 16,886 ------- --------------- DSBP 15,216 ------- --------------- --------------------- ----------------------------------------------- d) Aggregated Price No. of shares information 0p 133,728 -------------- --------------------- ----------------------------------------------- e) Date of the 26 September 2019 transaction --------------------- ----------------------------------------------- f) Place of the Not on a trading venue transaction --------------------- -----------------------------------------------
Contacts
Investors NMC Simon Watkins, Group Company Secretary +44 (0)20 3205 7313 Media FTI Consulting, London Brett Pollard +44 (0)20 3727 1000 FTI Consulting, Gulf Shane Dolan +971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHSELFEWFUSEDU
(END) Dow Jones Newswires
September 27, 2019 09:00 ET (13:00 GMT)
1 Year Nmc Health Chart |
1 Month Nmc Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions